Human WDR6 ORF/cDNA clone-Adenovirus particle (NM_018031.4)

Cat. No.: vGMAD000288

Pre-made Human WDR6/ Adenovirus for WDR6 overexpression in-vitro and in-vivo. The WDR6 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified WDR6-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to WDR6/ products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAD000288 Human WDR6 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAD000288
Gene Name WDR6
Accession Number NM_018031.4
Gene ID 11180
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 3456 bp
Gene Alias
Fluorescent Reporter GFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGGGCAGCGCGGCGCGCTGGGAAGGCTCGTTCTCGCGAGAGTTCAGCTCCCTTCTTAGCCGTGGCTGCCTCAGCACCTCGAGGATCGACATGGACGCTCTCGAGGACTACGTTTGGCCGCGGGCAACCTCGGAGCTTATACTCCTCCCAGTGACGGGTCTGGAGTGCGTGGGGGACCGGCTGTTGGCGGGTGAGGGTCCCGATGTCCTGGTGTACAGCTTGGACTTTGGTGGGCATCTGCGGATGATAAAGCGAGTGCAGAACCTGCTTGGCCACTATCTTATCCATGGCTTCCGGGTACGGCCAGAGCCTAATGGAGACCTTGACTTGGAGGCCATGGTGGCTGTGTTTGGAAGCAAGGGACTCCGAGTTGTGAAAATTAGCTGGGGACAGGGCCACTTCTGGGAGCTTTGGCGCTCTGGCCTGTGGAACATGTCTGACTGGATTTGGGATGCACGCTGGCTTGAGGGAAATATAGCCTTGGCCCTGGGCCACAACTCAGTGGTGCTATATGACCCTGTAGTAGGGTGCATCCTGCAAGAGGTGCCCTGCACAGACAGGTGCACCCTCTCTTCAGCCTGCCTGATTGGAGACGCCTGGAAGGAGCTGACCATAGTGGCAGGTGCTGTTTCCAACCAGCTCTTGGTCTGGTACCCAGCAACTGCCTTAGCAGACAACAAACCTGTAGCACCTGACCGACGAATCAGTGGGCATGTGGGCATCATCTTCAGCATGTCATACCTGGAAAGCAAGGGATTGCTGGCTACAGCTTCAGAAGACCGAAGCGTTCGTATCTGGAAGGTGGGCGACCTGCGAGTGCCTGGGGGTCGGGTGCAGAATATTGGGCACTGCTTTGGGCACAGCGCCCGTGTGTGGCAGGTCAAGCTTCTAGAGAATTACCTTATCAGTGCAGGAGAGGATTGTGTCTGCTTGGTGTGGAGCCATGAAGGTGAGATCCTCCAGGCCTTTCGGGGACACCAGGGACGTGGGATCCGGGCCATAGCTGCCCATGAGAGGCAGGCCTGGGTGATCACTGGGGGTGATGACTCAGGCATTCGGCTGTGGCACTTGGTAGGGCGTGGGTACCGGGGATTGGGGGTCTCGGCTCTCTGCTTCAAGTCCCGTAGTAGGCCAGGTACACTCAAGGCTGTGACTCTGGCTGGCTCTTGGCGACTGCTGGCAGTGACTGATACAGGGGCCCTGTATCTCTATGACGTCGAGGTCAAGTGCTGGGAGCAGCTGCTAGAGGATAAACATTTCCAGTCCTACTGCCTGCTGGAGGCAGCTCCTGGTCCCGAGGGCTTCGGATTGTGTGCTATGGCCAATGGGGAAGGTCGTGTCAAGGTTGTCCCCATCAACACTCCAACTGCTGCTGTGGACCAGACCCTGTTTCCTGGGAAGGTGCACAGCTTGAGCTGGGCCCTGCGTGGTTATGAGGAGCTCCTGTTGCTGGCATCGGGCCCTGGCGGGGTAGTAGCTTGCCTAGAGATCTCAGCCGCACCCTCTGGCAAGGCCATCTTTGTCAAGGAACGTTGTCGGTACCTGCTGCCCCCAAGCAAGCAGAGATGGCACACATGCAGTGCCTTCCTACCCCCAGGTGACTTCCTGGTGTGTGGTGACCGCCGGGGCTCTGTGCTGCTATTCCCCTCCAGACCAGGTCTGCTCAAGGACCCTGGGGTGGGAGGCAAGGCTCGGGCTGGTGCTGGGGCACCTGTAGTGGGTAGTGGTAGTAGTGGGGGTGGGAATGCTTTCACTGGGTTGGGCCCAGTGTCTACCCTGCCCTCTCTGCACGGGAAGCAGGGTGTGACCTCAGTCACATGCCATGGTGGCTATGTGTATACCACAGGGCGTGATGGAGCCTACTACCAGCTGTTTGTACGAGACGGCCAGCTCCAGCCAGTCCTAAGGCAGAAGTCCTGTCGAGGCATGAACTGGCTAGCTGGGCTCCGTATAGTGCCCGATGGGAGCATGGTTATCCTGGGTTTCCATGCCAATGAGTTTGTGGTGTGGAACCCTCGGTCACACGAGAAGCTGCACATCGTCAACTGTGGTGGAGGGCACCGTTCGTGGGCATTCTCTGATACTGAGGCGGCCATGGCCTTTGCTTACCTCAAGGATGGGGATGTCATGCTGTACAGGGCTCTGGGTGGCTGCACCCGGCCACACGTGATTCTCCGGGAGGGTCTGCATGGCCGTGAGATCACTTGTGTAAAGCGTGTGGGCACCATTACCCTGGGGCCTGAATATGGAGTGCCCAGCTTCATGCAGCCTGATGACCTGGAGCCTGGCAGTGAGGGGCCCGACTTGACTGACATTGTGATCACATGTAGTGAGGACACTACTGTCTGTGTCCTAGCACTCCCTACAACCACAGGCTCAGCCCACGCACTCACAGCTGTTTGTAACCATATCTCCTCGGTACGTGCTGTGGCTGTGTGGGGCATTGGCACCCCAGGTGGCCCTCAGGATCCTCAGCCAGGCCTGACTGCCCATGTGGTGTCTGCGGGGGGGCGGGCTGAGATGCACTGCTTCAGCATCATGGTTACTCCGGACCCCAGCACCCCAAGCCGCCTCGCCTGCCATGTCATGCACCTTTCGTCCCACCGGCTAGATGAGTATTGGGACCGGCAACGCAATCGGCATCGGATGGTTAAGGTAGACCCAGAGACCAGGTACATGTCCCTTGCTGTGTGTGAACTTGACCAGCCCGGCCTTGGCCCCCTTGTGGCTGCAGCCTGTAGTGATGGGGCCGTAAGGCTCTTTCTTTTGCAGGATTCTGGGCGGATTCTGCAGCTCCTTGCTGAAACCTTCCACCATAAGCGATGTGTCCTCAAGGTCCACTCCTTTACACACGAGGCACCCAACCAGAGGCGGAGGCTCCTCCTGTGCAGCGCAGCTACTGATGGCAGCCTGGCTTTCTGGGATCTCACCACCATGCTAGACCATGACTCCACTGTCCTGGAGCCTCCAGTGGATCCTGGGCTTCCCTACCGGCTTGGCACCCCCTCCCTGACTCTCCAGGCCCACAGCTGTGGTATCAACAGCCTGCACACCTTGCCCACCCGTGAGGGCCACCATCTCGTGGCCAGTGGCAGTGAAGATGGATCCCTCCATGTCTTCGTGCTTGCTGTGGAGATGCTACAGCTAGAAGAGGCTGTGGGAGAGGCTGGGCTGGTACCCCAGCTGCGTGTGCTAGAGGAATACTCTGTCCCCTGTGCACATGCTGCCCATGTGACAGGCCTCAAGATCCTAAGCCCAAGCATCATGGTCTCAGCCTCCATTGATCAACGGCTGACCTTCTGGCGTCTGGGGCATGGTGAACCCACCTTCATGAATAGCACTGTGTTCCATGTGCCTGATGTGGCTGACATGGACTGCTGGCCTGTGAGCCCTGAGTTTGGCCACCGTTGTGCCCTTGGGGGTCAGGGGCTTGAGGTTTACAACTGGTATGACTGA
ORF Protein Sequence MGSAARWEGSFSREFSSLLSRGCLSTSRIDMDALEDYVWPRATSELILLPVTGLECVGDRLLAGEGPDVLVYSLDFGGHLRMIKRVQNLLGHYLIHGFRVRPEPNGDLDLEAMVAVFGSKGLRVVKISWGQGHFWELWRSGLWNMSDWIWDARWLEGNIALALGHNSVVLYDPVVGCILQEVPCTDRCTLSSACLIGDAWKELTIVAGAVSNQLLVWYPATALADNKPVAPDRRISGHVGIIFSMSYLESKGLLATASEDRSVRIWKVGDLRVPGGRVQNIGHCFGHSARVWQVKLLENYLISAGEDCVCLVWSHEGEILQAFRGHQGRGIRAIAAHERQAWVITGGDDSGIRLWHLVGRGYRGLGVSALCFKSRSRPGTLKAVTLAGSWRLLAVTDTGALYLYDVEVKCWEQLLEDKHFQSYCLLEAAPGPEGFGLCAMANGEGRVKVVPINTPTAAVDQTLFPGKVHSLSWALRGYEELLLLASGPGGVVACLEISAAPSGKAIFVKERCRYLLPPSKQRWHTCSAFLPPGDFLVCGDRRGSVLLFPSRPGLLKDPGVGGKARAGAGAPVVGSGSSGGGNAFTGLGPVSTLPSLHGKQGVTSVTCHGGYVYTTGRDGAYYQLFVRDGQLQPVLRQKSCRGMNWLAGLRIVPDGSMVILGFHANEFVVWNPRSHEKLHIVNCGGGHRSWAFSDTEAAMAFAYLKDGDVMLYRALGGCTRPHVILREGLHGREITCVKRVGTITLGPEYGVPSFMQPDDLEPGSEGPDLTDIVITCSEDTTVCVLALPTTTGSAHALTAVCNHISSVRAVAVWGIGTPGGPQDPQPGLTAHVVSAGGRAEMHCFSIMVTPDPSTPSRLACHVMHLSSHRLDEYWDRQRNRHRMVKVDPETRYMSLAVCELDQPGLGPLVAAACSDGAVRLFLLQDSGRILQLLAETFHHKRCVLKVHSFTHEAPNQRRRLLLCSAATDGSLAFWDLTTMLDHDSTVLEPPVDPGLPYRLGTPSLTLQAHSCGINSLHTLPTREGHHLVASGSEDGSLHVFVLAVEMLQLEEAVGEAGLVPQLRVLEEYSVPCAHAAHVTGLKILSPSIMVSASIDQRLTFWRLGHGEPTFMNSTVFHVPDVADMDCWPVSPEFGHRCALGGQGLEVYNWYD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP2385-Ab Anti-WDR6 monoclonal antibody
    Target Antigen GM-Tg-g-MP2385-Ag WDR6 VLP (virus-like particle)
    ORF Viral Vector pGMAD000288 Human WDR6 Adenovirus plasmid
    ORF Viral Vector vGMAD000288 Human WDR6 Adenovirus particle


    Target information

    Target ID GM-MP2385
    Target Name WDR6
    Gene ID 11180, 83669, 708505, 301007, 101101370, 608948, 526884, 100063394
    Gene Symbol and Synonyms Trm734,WDR6
    Uniprot Accession Q9NNW5
    Uniprot Entry Name WDR6_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000178252
    Target Classification Not Available

    This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. The encoded protein interacts with serine/threonine kinase 11, and is implicated in cell growth arrest. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.